| Lenalidomide induces ubiquitination and degradation of CK1α in del (5q) MDS J Krönke, EC Fink, PW Hollenbach, KJ MacBeth, SN Hurst, ND Udeshi, ... Nature 523 (7559), 183-188, 2015 | 823 | 2015 |
| Core circadian clock genes regulate leukemia stem cells in AML RV Puram, MS Kowalczyk, CG de Boer, RK Schneider, PG Miller, ... Cell 165 (2), 303-316, 2016 | 234 | 2016 |
| Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein M Järås, P Johnels, N Hansen, H Ågerstam, P Tsapogas, M Rissler, ... Proceedings of the National Academy of Sciences 107 (37), 16280-16285, 2010 | 223 | 2010 |
| Role of casein kinase 1A1 in the biology and targeted therapy of del (5q) MDS RK Schneider, V Adema, D Heckl, M Järås, M Mallo, AM Lord, LP Chu, ... Cancer cell 26 (4), 509-520, 2014 | 206 | 2014 |
| In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling PG Miller, F Al-Shahrour, KA Hartwell, LP Chu, M Järås, RV Puram, ... Cancer cell 24 (1), 45-58, 2013 | 180 | 2013 |
| Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells M Nilsson, J Ljungberg, J Richter, T Kiefer, M Magnusson, A Lieber, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004 | 147 | 2004 |
| Niche-based screening identifies small-molecule inhibitors of leukemia stem cells KA Hartwell, PG Miller, S Mukherjee, AR Kahn, AL Stewart, DJ Logan, ... Nature chemical biology 9 (12), 840-848, 2013 | 137 | 2013 |
| Natural killer cells in myeloid malignancies: immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells M Carlsten, M Järås Frontiers in immunology 10, 489241, 2019 | 136 | 2019 |
| Selective killing of candidate AML stem cells by antibody targeting of IL1RAP M Askmyr, H Ågerstam, N Hansen, S Gordon, A Arvanitakis, M Rissler, ... Blood, The Journal of the American Society of Hematology 121 (18), 3709-3713, 2013 | 135 | 2013 |
| Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia H Ågerstam, C Karlsson, N Hansen, C Sandén, M Askmyr, S von Palffy, ... Proceedings of the National Academy of Sciences 112 (34), 10786-10791, 2015 | 127 | 2015 |
| IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models H Ågerstam, N Hansen, S von Palffy, C Sandén, K Reckzeh, C Karlsson, ... Blood, The Journal of the American Society of Hematology 128 (23), 2683-2693, 2016 | 104 | 2016 |
| Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia M Järås, PG Miller, LP Chu, RV Puram, EC Fink, RK Schneider, ... Journal of Experimental Medicine 211 (4), 605-612, 2014 | 103 | 2014 |
| Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells LP Vu, C Prieto, EM Amin, S Chhangawala, A Krivtsov, MN Calvo-Vidal, ... Nature genetics 49 (6), 866-875, 2017 | 87 | 2017 |
| In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets E Arbajian, F Puls, CR Antonescu, F Amary, R Sciot, M Debiec-Rychter, ... Clinical Cancer Research 23 (23), 7426-7434, 2017 | 78 | 2017 |
| CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting N Landberg, S von Palffy, M Askmyr, H Lilljebjörn, C Sandén, M Rissler, ... haematologica 103 (3), 447, 2018 | 54 | 2018 |
| Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism M Nilsson, S Karlsson, X Fan Molecular Therapy 9 (3), 377-388, 2004 | 53 | 2004 |
| IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome N Landberg, N Hansen, M Askmyr, H Ågerstam, C Lassen, M Rissler, ... Leukemia 30 (1), 255-258, 2016 | 50 | 2016 |
| De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia A Hyrenius-Wittsten, M Pilheden, H Sturesson, J Hansson, MP Walsh, ... Nature Communications 9 (1), 1770, 2018 | 45 | 2018 |
| Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner P Peña-Martínez, M Eriksson, R Ramakrishnan, M Chapellier, C Högberg, ... Leukemia 32 (3), 588-596, 2018 | 44 | 2018 |
| Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells M Eriksson, P Peña-Martínez, R Ramakrishnan, M Chapellier, C Högberg, ... Blood advances 1 (23), 2046-2057, 2017 | 42 | 2017 |
